KOL Interview: Dr. George Bakris

Spherix’s Jennifer Robinson interviews nephrology key opinion leader, Dr. George Bakris from University of Chicago Medicine, on the current state of the SGLT2 inhibitor market in diabetic kidney disease and the potential for finerenone and beyond.

Disclosure: This session was independently sponsored by Spherix Global Insights and not on behalf of a specific pharmaceutical company.